Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Grand Brilliance Group Holdings Current Ratio?
Grand Brilliance Group HoldingsHKSE:08372 66 Current Ratio is 7.59 as of Mar. 2026, which is 16% above its 10-year median of 6.56. GuruFocus rates HKSE:08372 with a GF Score™ of 66/100 and a GF Value™ of HK$0.12 (Fairly Valued). The stock has 5 warning signs investors should review. Among 120 Medical Distribution companies, Grand Brilliance Group Holdings ranks better than 95% on this metric.
Grand Brilliance Group Holdings has a current ratio of 7.59. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Grand Brilliance Group Holdings's Current Ratio or its related term are showing as below:
HKSE:08372'
s Current Ratio Range Over the Past 10 Years
Min: 5.8 Med: 6.56 Max: 9.29
Current: 7.59
During the past 11 years, Grand Brilliance Group Holdings's highest Current Ratio was 9.29. The lowest was 5.80. And the median was 6.56.
HKSE:08372's Current Ratio is ranked better than 95% of 120
companies
in the Medical Distribution industry
Industry Median: 1.395
vs HKSE:08372: 7.59
Grand Brilliance Group Holdings (HKSE:08372) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Grand Brilliance Group Holdings Current Ratio Related Terms
Grand Brilliance Group Holdings Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Grand Brilliance Group Holdings Current Ratio Chart
HKSE:08372 vs MCK, COR, CAH: Current Ratio Comparison
For the Medical Distribution subindustry, Grand Brilliance Group Holdings's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grand Brilliance Group Holdings Current Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Grand Brilliance Group Holdings's Current Ratio distribution charts can be found below:
* The bar in red indicates where Grand Brilliance Group Holdings's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Grand Brilliance Group Holdings (HKSE:08372) has a Current Ratio of 7.59 as of Mar. 2026. This is 16% above median its historical median of 6.56. Over the past decade, Grand Brilliance Group Holdings' Current Ratio has ranged from 5.80 to 9.29. According to the industry distribution chart, Grand Brilliance Group Holdings ranks #6 out of 120 companies in the Medical Distribution industry, placing it in the top 5%.
Is Grand Brilliance Group Holdings' Current Ratio too high?
Grand Brilliance Group Holdings' current Current Ratio of 7.59 is 16% above median its 10-year median of 6.56. Over the past 10 years, this metric has ranged from a low of 5.80 to a high of 9.29. The Medical Distribution industry median Current Ratio is 1.40. Grand Brilliance Group Holdings' value of 7.59 is 444.1% above this industry median. Based on the distribution chart, Grand Brilliance Group Holdings ranks #6 out of 120 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Grand Brilliance Group Holdings has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Grand Brilliance Group Holdings' Current Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Grand Brilliance Group Holdings ranks #6 out of 120 companies for Current Ratio. This places Grand Brilliance Group Holdings in the top 5% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.40. Grand Brilliance Group Holdings' value of 7.59 is 444.1% above this benchmark. Historically, Grand Brilliance Group Holdings' own Current Ratio has ranged from 5.80 to 9.29 over the past decade. While the company's 10-year median is 6.56 vs. the industry median of 1.40, Grand Brilliance Group Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Distribution company?
The median Current Ratio among Medical Distribution companies is 1.40, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grand Brilliance Group Holdings's current Current Ratio of 7.59 is 444.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median Current Ratio is 1.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grand Brilliance Group Holdings's current Current Ratio is 7.59, which is 16% above median its own 10-year median of 6.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grand Brilliance Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, Grand Brilliance Group Holdings (HKSE:08372) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.12, compared to a current price of HK$0.13 — trading 5.8% above its estimated fair value. The current Current Ratio is 7.59, which is 16% above median its 10-year median of 6.56 and 444.1% above the Medical Distribution industry median of 1.40. Grand Brilliance Group Holdings' overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Grand Brilliance Group Holdings (HKSE:08372), the current Current Ratio is 7.59 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Grand Brilliance Group Holdings (HKSE:08372) Overvalued in 2026?
Based on GuruFocus' analysis, Grand Brilliance Group Holdings stock appears to be overvalued.
The current stock price of HK$0.13 is trading 5.8% above its estimated GF Value™ of HK$0.12.
GuruFocus considers Grand Brilliance Group Holdings to be Fairly Valued.
Key valuation signals for HKSE:08372:
Current Ratio: 7.59 (16% above median its 10-year median of 6.56)
GF Value™: HK$0.12 vs. price of HK$0.13 (5.8% above fair value)
Industry Position: 444.1% above the Medical Distribution median (#6 of 120)
No single metric tells the full story. See the HKSE:08372 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Grand Brilliance Group Holdings Ltd is an investment holding. The company is engaged in the business of medical device distribution. The company also provides one-stop medical device solutions, including market trend analysis, sourcing of medical devices, after-sale services, technical support, and training services, medical device leasing services, and quality assurance. Geographically, the company derives revenue from Hong Kong. It serves private hospitals, public hospitals, private clinics, non-profit organizations, universities, and individual end-users in Hong Kong.
66GF Score
Get the complete analysis for HKSE:08372
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08372 has been successfully added to your 
